Protein-driven RNA nanostructured devices that function in vitro and control mammalian cell fate

• Published in: Nature communications 2017-09, Vol.8 (1), p.540-13, Article 540
• Main Authors: Shibata, Tomonori, Fujita, Yoshihiko, Ohno, Hirohisa, Suzuki, Yuki, Hayashi, Karin, Komatsu, Kaoru R., Kawasaki, Shunsuke, Hidaka, Kumi, Yonehara, Shin, Sugiyama, Hiroshi, Endo, Masayuki, Saito, Hirohide
• Format: Article
• Language: English
• Subjects: 631/45/500; 631/553/552; 631/61/350/2093; Apoptosis; Assembly; Cell fate; Cell Survival; Construction; Devices; HeLa Cells; Humanities and Social Sciences; Humans; In vitro methods and tests; Mammalian cells; Mammals; multidisciplinary; Nanostructure; Nanostructures - chemistry; Nanotechnology; Nanotechnology - instrumentation; Nanotechnology - methods; Nanotechnology devices; Nucleic acids; Oligomerization; Protein interaction; Protein structure; Proteins; Regulatory proteins; Ribonucleic acid; RNA; RNA - chemistry; RNA - genetics; RNA - metabolism; RNA-binding protein; RNA-Binding Proteins - chemistry; RNA-Binding Proteins - genetics; RNA-Binding Proteins - metabolism; Scaffolds; Science; Science (multidisciplinary); Target detection; Therapeutic applications
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-017-00459-x

Nucleic acid nanotechnology has great potential for future therapeutic applications. However, the construction of nanostructured devices that control cell fate by detecting and amplifying protein signals has remained a challenge. Here we design and build protein-driven RNA-nanostructured devices that actuate in vitro by RNA-binding-protein-inducible conformational change and regulate mammalian cell fate by RNA–protein interaction-mediated protein assembly. The conformation and function of the RNA nanostructures are dynamically controlled by RNA-binding protein signals. The protein-responsive RNA nanodevices are constructed inside cells using RNA-only delivery, which may provide a safe tool for building functional RNA–protein nanostructures. Moreover, the designed RNA scaffolds that control the assembly and oligomerization of apoptosis-regulatory proteins on a nanometre scale selectively kill target cells via specific RNA–protein interactions. These findings suggest that synthetic RNA nanodevices could function as molecular robots that detect signals and localize target proteins, induce RNA conformational changes, and programme mammalian cellular behaviour. Nucleic acid nanotechnology has great potential for future therapeutic applications. Here the authors build protein-driven RNA nanostructures that can function within mammalian cells and regulate the cell fate.